MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41390-024-03475-y

Медицинская библиотека · Pediatric research · 2024

Comparison of standard and global hemostasis assays in cord and peripheral blood of newborns.

Arutunyan Belinda V, Koltsova Ekaterina M, Shpilyuk Margarita A, Lipets Elena N, Timofeeva Leila A, Karavaeva Anna L, Balashova Ekaterina N, Krechetova Liubov V, Ataullakhanov Fazoil I, Zubkov Viktor V, Degtyarev Dmitry N, Sukhikh Gennady T, Tetruashvili Nana K, Balandina Anna N

СтатьяСравнительное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Umbilical cord blood is used for the testing of various parameters in newborns. However, data on its applicability for hemostasis assays is insufficient.

OBJECTIVE

To evaluate whether umbilical cord blood can be used for standard tests, thromboelastometry and thrombodynamics for preterm and term newborns.

METHODS

187 newborns were included in the study. Blood was taken from the umbilical cord and by venipuncture of the newborn. Clotting times, fibrinogen, D-dimer, thromboelastometry and thrombodynamics were measured.

RESULTS

Clotting times and fibrinogen indicated a hypocoagulable shift, while thromboelastometry and thrombodynamics showed a hypercoagulable shift in hemostasis in umbilical cord blood compared to newborn blood. D-dimer indicated an enhanced process of thrombus lysis in newborn blood compared to cord blood. Collecting blood into a tube with the addition of a contact pathway inhibitor did not significantly change the global assay parameters in either umbilical cord blood or newborn blood. In the thrombodynamics assay, spontaneous clotting was detected but suppressed by the addition of a tissue factor inhibitor.

CONCLUSIONS

Hemostasis in cord and newborn blood differs for both global and standard tests. Hypercoagulability in newborns registered with the global assay thrombodynamics is associated with the presence of tissue factor in the blood.

IMPACT STATEMENT: 1. We found a hypercoagulation shift in newborns compared with the adult references, possibly due to the presence of tissue factor in blood. 2. Blood coagulation is enhanced in cord blood compared with blood sampled from the vein of a newborn according to thromboelastometry and thrombodynamics assays. 3. Clotting times and fibrinogen concentrations in cord blood differ from these parameters in newborn blood. 4. Studying of the (patho)physiological features of hemostasis in newborns should consider differences in cord blood and vein sampled blood.

Для цитирования: Arutunyan Belinda V, Koltsova Ekaterina M, Shpilyuk Margarita A, Lipets Elena N, Timofeeva Leila A, Karavaeva Anna L, Balashova Ekaterina N, Krechetova Liubov V, Ataullakhanov Fazoil I, Zubkov Viktor V, Degtyarev Dmitry N, Sukhikh Gennady T, Tetruashvili Nana K, Balandina Anna N. Comparison of standard and global hemostasis assays in cord and peripheral blood of newborns.. Pediatric research. 2024. DOI: 10.1038/s41390-024-03475-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.